Annual Debt To Equity
-0.08
-0.12-300.00%
December 1, 2023
Summary
- As of February 10, 2025, NRSN annual debt to equity ratio is -0.08, with the most recent change of -0.12 (-300.00%) on December 1, 2023.
- During the last 3 years, NRSN annual debt to equity has fallen by -0.08 (-100.00%).
- NRSN annual debt to equity is now -300.00% below its all-time high of 0.04, reached on December 31, 2022.
Performance
NRSN Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
-0.01
+0.01+50.00%
September 1, 2024
Summary
- As of February 10, 2025, NRSN quarterly debt to equity ratio is -0.01, with the most recent change of +0.01 (+50.00%) on September 1, 2024.
- Over the past year, NRSN quarterly debt to equity has stayed the same.
- NRSN quarterly debt to equity is now -125.00% below its all-time high of 0.04, reached on December 31, 2022.
Performance
NRSN Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
NRSN Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -300.0% | 0.0% |
| 3 y3 years | -100.0% | -150.0% |
| 5 y5 years | -100.0% | - |
NRSN Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -300.0% | at low | -125.0% | +97.7% |
| 5 y | 5-year | -300.0% | at low | -125.0% | +97.7% |
| alltime | all time | -300.0% | at low | -125.0% | +97.7% |
NeuroSense Therapeutics Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -0.01(-50.0%) |
| Jun 2024 | - | -0.02(+100.0%) |
| Mar 2024 | - | -0.01(-87.5%) |
| Dec 2023 | -0.08(-300.0%) | -0.08(-81.4%) |
| Sep 2023 | - | -0.43(+514.3%) |
| Jun 2023 | - | -0.07(-275.0%) |
| Mar 2023 | - | 0.04(0.0%) |
| Dec 2022 | 0.04 | 0.04(+100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | 0.02(0.0%) |
| Jun 2022 | - | 0.02(0.0%) |
| Mar 2022 | - | 0.02(>+9900.0%) |
| Dec 2021 | 0.00(0.0%) | - |
| Dec 2021 | - | 0.00(0.0%) |
| Jun 2021 | - | 0.00(0.0%) |
| Dec 2020 | 0.00(0.0%) | 0.00 |
| Dec 2019 | 0.00 | - |
FAQ
- What is NeuroSense Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics annual debt to equity year-on-year change?
- What is NeuroSense Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics quarterly debt to equity year-on-year change?
What is NeuroSense Therapeutics annual debt to equity ratio?
The current annual debt to equity of NRSN is -0.08
What is the all time high annual debt to equity for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high annual debt to equity ratio is 0.04
What is NeuroSense Therapeutics annual debt to equity year-on-year change?
Over the past year, NRSN annual debt to equity ratio has changed by -0.12 (-300.00%)
What is NeuroSense Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of NRSN is -0.01
What is the all time high quarterly debt to equity for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high quarterly debt to equity ratio is 0.04
What is NeuroSense Therapeutics quarterly debt to equity year-on-year change?
Over the past year, NRSN quarterly debt to equity ratio has changed by 0.00 (0.00%)